Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Building models for rare diseases

Posted on June 2nd, 2016 by in Pharma R&D

We continue the series of stories about the exciting collaboration between the UK charity Findacure and Elsevier. Findacure’s mission is to empower rare disease patient groups, facilitate treatment Continue reading “Building models for rare diseases” »

Using Text Mining to Find Treatments for Rare Diseases

Posted on May 5th, 2016 by in Pharma R&D

When you compare PubMed search results for rare diseases, such as “congenital hyperinsulinism” (767), schwannomatosis (250) or “Mabry syndrome” (34), to that of “diabetes” (542,987), “heart attack” (217,694) or “obesity” (237,307), the disparity in attention becomes much more obvious. Continue reading “Using Text Mining to Find Treatments for Rare Diseases” »

Drug Repurposing for Rare Diseases

Posted on April 27th, 2016 by in Pharma R&D

Elsevier’s partnership with a UK charity Findacure started last year with a very touching and inspirational talk from Dr. Nick Sireau, a parent of two children diagnosed with alkaptonuria. Very soon after his first child was born, Nick found himself Continue reading “Drug Repurposing for Rare Diseases” »